2. www.charnwood-molecular.com 2
Chemistry for Drug Discovery
Our USPs are our people & our capabilities
Innovative Medicinal Chemistry team
Highly experienced early PR&D Group
Network of strategic Drug Discovery partners
Independent, UK-based CRO of over 20 years
>60 employees, 85% PhDs
International: scientists and clients
Synthetic & Medicinal Chemistry expertise
9. www.charnwood-molecular.com 9
Beutner Amidation - transformation map
Beutner et al. Org. Lett. 2018, 20, 4218−4222
Both products
amenable to
subsequent
SNAr reaction
Recent discovery project
10. www.charnwood-molecular.com
Conclusions
• The synthetic considerations of discovery a development chemists are different
• Designing your syntheses with an awareness of the challenges of development
chemistry could save time and money
• Transformation maps provide a detailed understanding of the potential challenges
and opportunities in any reaction
• Build a transformation map and think about the rate processes driving the different
reactions taking place in your flask
• Engage each other and work collaboratively to design chemical processes that work
efficiently regardless of the stage in the drug discovery process
• Thank you for listening!
10
11. www.charnwood-molecular.com 11
…for reliable, flexible Drug Discovery Outsourcing
from Lead Discovery through to pre-clinical Scale-up
Independent, UK-based CRO of 20 years
2 Sites, 40+ employees, 82% PhDs
International: scientists and clients
Synthetic Organic Chemistry experts
Our USPs are our people & our capabilities
Innovative Medicinal Chemistry team,
from Pharma, Research Institutes & start-ups
Big Pharma-experienced early PR&D Group
100% Service business model (FTE or FFS)
Network of strategic, expert Drug Discovery partners
Excellence in Chemistry
Editor's Notes
Maybe go for “how do I design out a hERG liability or address and efflux issue”
Versus “How do I synthesis 2 Kg of this clinical candidate in the most cost effective, atom economical and environmentally benign manner without using column chromatography
Designing compound versus designing synthesis
Maybe go for “how do I design out a hERG liability or address and efflux issue”
Versus “How do I synthesis 2 Kg of this clinical candidate in the most cost effective, atom economical and environmentally benign manner without using column chromatography
But before we consider the differences between dd and development, we should consider where
Lates stage functionalisation for known?
Where do they come from?......and the typeof technique has, as you might expect, a pronounced impact on the types of hit you get, which in turn will impact on the complexity of the synthetic strategy. Whatever the case may be, the synthetic strategy is invariable executed in the same way.
The type of hit finding platform used will have an impact on the medicinal chemistry strtagey
Despite some of the differences discussed today, discovery and development chemists share a common background in synthetic chemistry and this is something that they should collaboratively use to their advantage to develop robust processes.